Effect of low-dose positive inotropic drugs on human internal mammary artery flow

Annals of Thoracic Surgery

Volumn 64, Issue 6, 1997, Pages 1742-1746

  Cracowski, Jean Luc ^a,b   Chavanon, Olivier ^a   Durand, Michel ^a   Borrel, Elisabeth ^a   Devillier, Philippe ^a   Mallion, Jean Michel ^a   Blin, Dominique ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; ENOXIMONE; INOTROPIC AGENT;

ADULT; ARTERY BLOOD FLOW; ARTERY GRAFT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEMODYNAMICS; HUMAN; INOTROPISM; INTERNAL MAMMARY ARTERY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ADULT; AGED; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; DOBUTAMINE; DOUBLE-BLIND METHOD; ENOXIMONE; EPINEPHRINE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MAMMARY ARTERIES; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS;

EID: 0031425287     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)01103-X     Document Type: Article

References (18)

1. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal thoracic artery grafts. Effects on survival over a 15-year period. N Engl J Med. 334:1996;216-219.
2. Grondin CM, Campeau L, Lesperance J, Enjalbert M, Bourassa MG. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation. 70:(Suppl 1):1984;208-212.
3. Okies JE, Page S, Bigelow JC, Krause AH, Salomon NW. The left internal mammary artery the graft of choice . Circulation. 70:(Suppl 1):1984;213-221.
4. Jones EL, Lattouf OM, Weintraub WS. Catastrophic consequences of internal mammary artery hypoperfusion. J Thorac Cardiovasc Surg. 98:1989;902-907.
5. Sarabu MR, Clung JA, Fass A, Reed GE. Early postoperative spasm in the left internal mammary artery bypass grafts. Ann Thorac Surg. 44:1987;195-200.
6. Dinardo JA, Bert A, Schwartz MJ, Johnson RG, Thurer RL, Weintraub RM. Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man. J Thorac Cardiovasc Surg. 102:1991;730-735.
7. Izzat MB, West RR, Ragoonanan C, Angelini GD. Effect of systemic vasodilators on internal mammary artery flow. J Thorac Cardiovasc Surg. 108:1994;82-85.
8. Von Segesser LK, Lehmann K, Turina M. Deleterious effects of shock in internal mammary artery anastomoses. Ann Thorac Surg. 47:1989;575-579.
9. He GW, Buxton BF, Rosenfeldt FL, Angus JA, Tatoulis J. Pharmacologic dilatation of the internal mammary artery during coronary bypass. J Thorac Cardiovasc Surg. 107:1994;1440-1444.
10. Cooper GJ, Wilkinson AL, Angelini GD. Overcoming perioperative spasm of the internal mammary artery. Which is the best vasodilator? J Thorac Cardiovasc Surg. 104:1992;465-468.
11. Dregelid E, Keldal K, Resch F, Stangeland L, Breivik K, Svendsen E. Dilation of the internal mammary artery by external and intraluminal papaverine application. J Thorac Cardiovasc Surg. 110:1995;697-703.
12. Beloucif S, Laborde F, Beloucif L, Piwnica A, Payen D. Determinants of systolic and diastolic flow in coronary bypass grafts with inotropic stimulation. Anesthesiology. 73:1990;1127-1135.
13. Sakamoto T, Yamada T. Hemodynamic effects of dobutamine in patients following open heart surgery. Circulation. 55:1977;525-533.
14. Salomon NW, Plachetka JR, Copeland JG. Comparison of dopamine and dobutamine following coronary artery bypass grafting. Ann Thorac Surg. 33:1982;48-54.
15. Caroll JD, Lang RM, Neumann AL, Borow KM, Rajfer SI. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. Circulation. 4:1986;815-825.
16. Morita S, Sawai Y, Heeg J, Koike Y. Pharmacokinetics of enoximone after various intravenous administration to healthy volunteers. J Pharm Sci. 2:1995;152-157.
17. Boldt J, Kling D, Dieterich HA, Marck P, Hempelmann G. The new phosphodiesterase inhibitor enoximone in patients following cardiac surgery. Pharmacokinetics and influence on parameters of coagulation. Intensive Care Med. 16:1990;54-59.
18. Payen D, Dupuy P, Schurando P, Laborde F. Enoximone en postopératoire de chirurgie coronaire. Arch Mal Coeur. 83:(3):1990;13-17.